Schulz, S Charles <br/><br/>
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.  [electronic resource] 

 -  The British journal of psychiatry : the journal of mental science  Dec 2008 
 - 485-92 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1472-1465 
<br/><br/><label>Standard No.: </label>10.1192/bjp.bp.107.037903  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines--adverse effects<br/>Borderline Personality Disorder--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Olanzapine<br/>Psychiatric Status Rating Scales<br/>Treatment Outcome<br/>Weight Gain<br/>Young Adult